… deal value. By contrast, 3SBio pocketed a $1.25 billion … companies tend to balance commercial investment against projected returns, creating … than the 6 times for 3SBio, indicating that a chunky … been priced in. Still, investors should note that RemeGen reported …

Pfizer (PFE 0.56%) made a fortune thanks to its work in the COVID-19 market. In 2022, it became the first company in the biopharmaceutical industry to generate $100 billion in annual sales. However, the pandemic receded, and revenue in this area dropped …

Pfizer has entered into an exclusive global, ex-China, licensing agreement with 3SBio a Chinese biopharmaceutical company, listed on the Hong Kong Stock Exchange (HKEX), according to a May 19 company announcement.  ¬ Haymarket Media Limited. All rights …

… , Pfizer said, adding that 3SBio is planning to launch the … . The agreement will see 3SBio and its subsidiaries Shenyang Sunshine … in China. In exchange, 3SBio will receive $1.25bn upfront … make a $100m equity investment in 3SBio when the transaction closes, …

… a $100 million equity investment in the Chinese biotechnology company … trials in China and 3SBio plans to initiate the … commercialization rights in China. 3SBio said separately that the drug … product in McPherson, Kansas. 3SBio has facilities in China and …

… be partnering with Chinese biopharma 3SBIO in a licensing agreement, … a $100 million equity investment in 3SBIO based on a securities … product in McPherson, Kansas.  3SBIO said the drug has … are swaying drugmarkers to invest in manufacturing more products …

… giant will pay biotechnology company 3SBio $1.25 billion upfront for … a $100 million equity investment in 3SBio upon the deal’s closing … and grow. The wave of investment comes after one such drug … peers have been pledging more investment in U.S. drug production …

… terms of the agreement, 3SBio and its subsidiaries Shenyang … commercialization rights in China. 3SBio will receive an upfront … required regulatory approvals and 3SBio shareholder approval. Upon close … $100 million equity investment in 3SBio subject to an agreed …

… Kong’s stock market. 3SBio Inc. gained 32.28% … 52-week lows. Mainland investors purchased a net $808 … if these trends persist. Investor’s Business Daily recently published … Carlos Arancibia, “Bon Voyage, Investors,” highlighting the strong performance of …

… Capital Markets, writing to investors shortly after Pfizer’s … commercial milestones. Additionally, 3SBio will be eligible for tiered … market. The total potential investment is higher than other … VEGF bispecific. Pfizer and 3SBio expect to close the …